» Articles » PMID: 25267983

Opioids for Chronic Noncancer Pain: a Position Paper of the American Academy of Neurology

Overview
Journal Neurology
Specialty Neurology
Date 2014 Oct 1
PMID 25267983
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

The Patient Safety Subcommittee requested a review of the science and policy issues regarding the rapidly emerging public health epidemic of prescription opioid-related morbidity and mortality in the United States. Over 100,000 persons have died, directly or indirectly, from prescribed opioids in the United States since policies changed in the late 1990s. In the highest-risk group (age 35-54 years), these deaths have exceeded mortality from both firearms and motor vehicle accidents. Whereas there is evidence for significant short-term pain relief, there is no substantial evidence for maintenance of pain relief or improved function over long periods of time without incurring serious risk of overdose, dependence, or addiction. The objectives of the article are to review the following: (1) the key initiating causes of the epidemic; (2) the evidence for safety and effectiveness of opioids for chronic pain; (3) federal and state policy responses; and (4) recommendations for neurologists in practice to increase use of best practices/universal precautions most likely to improve effective and safe use of opioids and to reduce the likelihood of severe adverse and overdose events.

Citing Articles

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S252-S265.

PMID: 39651973 PMC: 11635040. DOI: 10.2337/dc25-S012.


Bedside Neuromodulation of Persistent Pain and Allodynia with Caloric Vestibular Stimulation.

Ngo T, Barsdell W, Law P, Arnold C, Chou M, Nunn A Biomedicines. 2024; 12(10).

PMID: 39457677 PMC: 11505407. DOI: 10.3390/biomedicines12102365.


Does opioid therapy enhance quality of life in patients suffering from chronic non-malignant pain? A systematic review and meta-analysis.

Kraft K, Backmund T, Eberhart L, Schubert A, Dinges H, Hagen M Br J Pain. 2024; 18(3):227-242.

PMID: 38751560 PMC: 11092930. DOI: 10.1177/20494637231216352.


A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET.

Sayed D, Deer T, Hagedorn J, Sayed A, DSouza R, Lam C J Pain Res. 2024; 17:1461-1501.

PMID: 38633823 PMC: 11022879. DOI: 10.2147/JPR.S451006.


Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia--induced neuropathy.

Lin H, Yang C, Yin T, Sung P, Chiang J, Shao P Am J Transl Res. 2023; 15(10):6264-6285.

PMID: 37969202 PMC: 10641353.